ANEBULO PHARMACEUTICALS
Anebulo is a clinical-stage biotechnology company developing novel solutions for people suffering from cannabinoid overdose and substance addiction. Its lead product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within one hour of administration. Clinical trials completed to date have shown that ANEB-001 is rapidly absorbed, well-tolerated, and leads to weight loss, an effect that is consistent with central cannabinoid receptor type 1 antagonism.
ANEBULO PHARMACEUTICALS
Industry:
Biotechnology Life Science MHealth
Founded:
2020-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.anebulo.com
Total Employee:
1+
Status:
Active
Contact:
512-598-0931
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Ataxion
Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Current Employees Featured
Founder
Stock Details
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-04 | Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director |
Official Site Inspections
http://www.anebulo.com Semrush global rank: 4.38 M Semrush visits lastest month: 2.56 K
- Host name: box2005.bluehost.com
- IP address: 74.220.219.155
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
